- Home
- ORGO vs DIN Comparison
ORGO vs DIN Comparison
Compare ORGO & DIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- DIN
- Stock Information
- Founded
- ORGO 1985
- DIN 1958
- Country
- ORGO United States
- DIN United States
- Employees
- ORGO N/A
- DIN N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- DIN Restaurants
- Sector
- ORGO Health Care
- DIN Consumer Discretionary
- Exchange
- ORGO Nasdaq
- DIN Nasdaq
- Market Cap
- ORGO 384.4M
- DIN 379.1M
- IPO Year
- ORGO N/A
- DIN 1991
- Fundamental
- Price
- ORGO $3.46
- DIN $26.36
- Analyst Decision
- ORGO Buy
- DIN Hold
- Analyst Count
- ORGO 2
- DIN 8
- Target Price
- ORGO $5.50
- DIN $26.33
- AVG Volume (30 Days)
- ORGO 911.8K
- DIN 435.4K
- Earning Date
- ORGO 08-07-2025
- DIN 08-06-2025
- Dividend Yield
- ORGO N/A
- DIN 7.73%
- EPS Growth
- ORGO N/A
- DIN N/A
- EPS
- ORGO N/A
- DIN 3.61
- Revenue
- ORGO $458,760,000.00
- DIN $820,851,000.00
- Revenue This Year
- ORGO $2.62
- DIN $8.51
- Revenue Next Year
- ORGO $12.46
- DIN $1.83
- P/E Ratio
- ORGO N/A
- DIN $7.31
- Revenue Growth
- ORGO 5.35
- DIN N/A
- 52 Week Low
- ORGO $2.28
- DIN $18.63
- 52 Week High
- ORGO $6.71
- DIN $38.68
- Technical
- Relative Strength Index (RSI)
- ORGO 54.42
- DIN 57.19
- Support Level
- ORGO $3.13
- DIN $26.08
- Resistance Level
- ORGO $3.36
- DIN $28.44
- Average True Range (ATR)
- ORGO 0.21
- DIN 1.10
- MACD
- ORGO 0.08
- DIN 0.01
- Stochastic Oscillator
- ORGO 74.36
- DIN 57.13
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.